Thanks Ringao for the signal of the long's emotional capitulation day, which fortunately neither you or others we've heard say dumped their shares. I own shares of HZNP as well, both stocks were mining new lows and on the same day both roared back to life, although PATH not as exuberantly as HZNP. It just goes to show how even well after FDA approval, there doesn't need to be a rush to own shares. Take for example ALXA, which even secured TEVA as a partner for the USA, with EMA approval in Europe and a partner there, their stock is still dragging anchor, whooshed to lows again just this week. Like you though, I know to focus beyond the pain to what I believe will be substantial profits. Good luck in your outcomes, Lord knows we've been tested here, although not like management. I can't begin to understand how they must feel as they've played their poker hand so long in their partnership or buyout talks.
Recent PATH News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 08:14:39 PM
- UiPath Reports First Quarter Fiscal 2027 Financial Results • Business Wire • 05/28/2026 08:10:00 PM
- UiPath to Participate in the William Blair 46th Annual Growth Stock Conference • Business Wire • 05/26/2026 08:10:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/22/2026 08:27:44 PM
- UiPath Named a Leader in Document Mining and Analytics Platforms by Independent Research Firm • Business Wire • 05/21/2026 08:30:00 PM
- Statement from UiPath on the passing of Board Member S. "Soma" Somasegar • Business Wire • 05/20/2026 03:38:00 PM
- UiPath Secures Winning Bid in Seattle Children’s Charity Auction for the 2026 World Cup Experience at Seattle’s Lumen Field • Business Wire • 05/20/2026 12:30:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/12/2026 08:45:40 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/12/2026 08:29:23 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/12/2026 08:28:42 PM
- UiPath Becomes First Business Orchestration & Automation Platform with Native Integration for Coding Agents, Unlocking Enterprise Transformation at Scale • Business Wire • 05/12/2026 12:30:00 PM
- UiPath Automation Suite™ Delivers On-Premises Agentic AI for the Public Sector • Business Wire • 05/05/2026 12:30:00 PM
- UiPath Announces First Quarter Fiscal 2027 Financial Results Conference Call • Business Wire • 04/30/2026 08:10:00 PM
- UiPath Accelerates New Agentic-led Software Testing Capability through Deloitte’s ASCEND Delivery Platform • Business Wire • 04/27/2026 01:00:00 PM
- UiPath Advances AI-Driven Enterprise Operations with Databricks Partnership • Business Wire • 04/27/2026 12:00:00 PM
- UiPath Brings its AI Document Processing Solution to Google Cloud Marketplace with Gemini-Powered Automation • Business Wire • 04/22/2026 12:30:00 PM
- UiPath Celebrates Five-Year Listing Anniversary at NYSE • PR Newswire (Canada) • 04/21/2026 12:55:00 PM
- UiPath Celebrates Five-Year Listing Anniversary at NYSE • PR Newswire (US) • 04/21/2026 12:55:00 PM
- UiPath Celebrates Five-Year Listing Anniversary at NYSE • PR Newswire (US) • 04/21/2026 12:55:00 PM
- UiPath Leadership to Ring Opening Bell at New York Stock Exchange to Mark Five-Year IPO Anniversary • Business Wire • 04/20/2026 08:30:00 PM
- UiPath Announces AI-Powered Orchestration and CX Automation on Salesforce AgentExchange • Business Wire • 04/16/2026 12:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/06/2026 08:26:30 PM
- UiPath to Showcase Latest Agentic Business Orchestration Capabilities and Product Strategy in Upcoming Webinar • Business Wire • 03/31/2026 08:10:00 PM
